Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin

Journal of Veterinary Pharmacology and Therapeutics

Volumn 34, Issue 4, 2011, Pages 313-321

  Real, R ^a   Egido, E ^a   Perez M ^a   Gonzalez Lobato L ^a   Barrera, B ^a   Prieto, J G ^a   Alvarez A I ^a   Merino, G ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DANOFLOXACIN; IVERMECTIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG TRANSPORT; FEMALE; MALE; MILK; MILK PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; IVERMECTIN; MALE; MICE; MILK; NEOPLASM PROTEINS; SHEEP;

MUS; OVIS ARIES;

EID: 79960092683     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01241.x     Document Type: Article

References (41)

1. Allen, J.D., van Loevezijn, A., Lakhai, J.M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J.H., Koomen, G.J. & Schinkel, A.H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Molecular Cancer Therapeutics, 1, 417-425.
2. Alvarez, A.I., Pérez, M., Prieto, J.G., Molina, A.J., Real, R. & Merino, G. (2008) Fluoroquinolone efflux mediated by ABC transporters. Journal of Pharmaceutical Science, 97, 3483-3493.
3. Ando, T., Kusuhara, H., Merino, G., Alvarez, A.I., Schinkel, A.H. & Sugiyama, Y. (2007) Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones. Drug Metabolism and Disposition, 35, 1873-1879.
4. Breedveld, P., Beijnen, J.H. & Schellens, J.H. (2006) Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends in Pharmacological Sciences, 27, 17-24.
5. Didier, A. & Loor, F. (1996) The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anti-Cancer Drugs, 7, 745-751.
6. Escudero, E., Cárceles, C.M., Fernandez-Varon, E., Marin, P. & Benchaoui, H. (2007) Pharmacokinetics of danofloxacin 18% in lactating sheep and goats. Journal of Veterinary Pharmacology and Therapeutics, 30, 572-577.
7. Garcia, M.A., Solans, C., Aramayona, J.J., Rueda, S. & Bregante, M.A. (2000) Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomedical Chromatography, 14, 89-92.
8. Giri, N., Agarwal, S., Shaik, N., Pan, G., Chen, Y. & Elmquist, W.F. (2009) Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design. Drug Metabolism and Disposition, 37, 560-570.
9. van Herwaarden, A.E. & Schinkel, A.H. (2006) The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends in Pharmacological Sciences, 27, 10-16.
10. van Herwaarden, A.E., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J.W. & Schinkel, A.H. (2006) Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis, 27, 123-130.
11. van Herwaarden, A.E., Wagenaar, E., Merino, G., Jonker, J.W., Rosing, H., Beijnen, J.H. & Schinkel, A.H. (2007) Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Molecular and Cellular Biology, 27, 1247-1253.
12. Huisman, M.T., Smit, J.W., Wiltshire, H.R., Hoetelmans, R.M., Beijnen, J.H. & Schinkel, A.H. (2001) P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir. Molecular Pharmacology, 59, 806-813.
13. Jani, M., Makai, I., Kis, E., Szabó, P., Nagy, T., Krajcsi, P. & Lespine, A. (2010) Ivermectin interacts with human ABCG2. Journal of Pharmaceutical Sciences, June 22 [Epub ahead of print] DOI: 10.1002/jps.22262.
14. Jonker, J.W., Smit, J.W., Brinkhuis, R.F., Maliepaard, M., Beijnen, J.H., Schellens, J.H.M. & Schinkel, A.H. (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. Journal of the National Cancer Institute, 92, 1651-1656.
15. Jonker, J.W., Merino, G., Musters, S., van Herwaarden, A.E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T.C. & Schinkel, A.H. (2005) The Breast Cancer Resistance Protein (BCRP/ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine, 11, 127-129.
16. Lifschitz, A., Virkel, G., Ballent, M., Sallovitz, J. & Lanusse, C. (2009) Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Veterinary Journal, 182, 261-268.
17. Lindecrona, R.H., Friis, C. & Nielsen, J.P. (2000) Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs. Research in Veterinary Science, 68, 211-216.
18. Marazuela, M.D. & Moreno-Bondi, M.C. (2004) Multiresidue determination of fluoroquinolones in milk by column liquid chromatography with fluorescence and ultraviolet absorbance detection. Journal of Chromatography A, 1034, 25-32.
19. McKellar, Q.A. & Benchaoui, H.A. (1996) Avermectins and milbemycins. Journal of Veterinary Pharmacology and Therapy, 19, 331-351.
20. McKellar, Q.A., Gibson, I.F. & McCormack, R.Z. (1998) Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition, 19, 123-129.
21. Merino, G., Jonker, J.W., Wagenaar, E., van Herwaarden, A.E. & Schinkel, A.H. (2005) The Breast Cancer Resistance Protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion and milk secretion of the antibiotic nitrofurantoin. Molecular Pharmacology, 67, 1758-1764.
22. Merino, G., Alvarez, A.I., Pulido, M.M., Molina, A.J., Schinkel, A.H. & Prieto, J.G. (2006) Breast Cancer Resistance Protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability pharmacokinetics and milk secretion. Drug Metabolism and Disposition, 34, 690-695.
23. Merino, G., Real, R., Baro, M.F., Gonzalez-Lobato, L., Prieto, J.G., Alvarez, A.I. & Marques, M.M. (2009) Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors. Drug Metabolism and Disposition, 37, 5-9.
24. Molyneux, D.H., Bradley, M., Hoerauf, A., Kyelem, D. & Taylor, M.J. (2003) Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends in Parasitology, 19, 516-522.
25. Muenster, U., Grieshop, B., Ickenroth, K. & Gnoth, M.J. (2008) Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharmaceutical Research, 25, 2320-2326.
26. Naruhashi, K., Tamai, I., Inoue, N., Muraoka, H., Sai, Y., Suzuki, N. & Tsuji, A. (2002) Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrobial Agents and Chemotherapy, 46, 344-349.
27. Noguchi, K., Katayama, K., Mitsuhashi, J. & Sugimoto, Y. (2009) Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Advanced Drug Delivery Reviews, 61, 26-33.
28. Pavek, P., Merino, G., Wagenaar, E., Bolscher, E., Novotna, M., Jonker, J.W. & Schinkel, A.H. (2005) Human breast cancer resistance protein (BCRP/ABCG2): interactions with steroid drugs, hormones, the dietary carcinogen PhIP, and transport of cimetidine. Journal of Pharmacology and Experimental Therapeutics, 312, 144-152.
29. Pérez, M., Blázquez, A.G., Real, R., Mendoza, G., Prieto, J.G., Merino, G. & Alvarez, A.I. (2009a) In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chemico-Biological Interactions, 180, 106-112.
30. Pérez, M., Real, R., Mendoza, G., Merino, G., Prieto, J.G. & Alvarez, A.I. (2009b) Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones. Journal of Veterinary Pharmacology and Therapeutics, 32, 498-502.
31. Poutrel, B., Stegemann, M.R., Roy, O., Pothier, F., Tilt, N. & Payne-Johnson, M. (2008) Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. Journal of Dairy Research, 75, 310-318.
32. Pulido, M.M., Molina, A.J., Merino, G., Prieto, J.G. & Álvarez, A.I. (2006) Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): Influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics, 29, 279-287.
33. Quattrocchi, O.A., Abelaira de Andrizzi, S.I. & Laba, R.F. (1992) Introducción al HPLC, Aplicación y Práctica, p. 323, Chapter 12. Ed. Artes Gráficas Farro SA, California.
34. Sasabe, H., Kato, Y., Suzuki, T., Itose, M., Miyamoto, G. & Sugiyama, Y. (2004) Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice. Journal of Veterinary Pharmacology and Therapeutics, 310, 648-655.
35. Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P., Berns, A.J.M. & Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502.
36. Schrickx, J.A. & Fink-Gremmels, J. (2007) Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. British Journal of Pharmacology, 150, 463-469.
37. Schrickx, J.A. & Fink-Gremmels, J. (2008) Implications of ABC transporters on the disposition of typical veterinary medicinal products. European Journal of Pharmacology, 585, 510-519.
38. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A. & Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics, 21, 209-213.
39. Wu, H.J., Luo, J., Wu, N., Matand, K., Zhang, L.J., Han, X.F. & Yang, B.J. (2008) Cloning, sequence and functional analysis of goat ATP-binding cassette transporter G2 (ABCG2). Molecular Biotechnology, 39, 21-27.
40. Zhang, Y., Wang, H., Unadkat, J.D. & Mao, Q. (2007) Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metabolism and Disposition, 35, 2154-2158.
41. Zhou, L., Naraharisetti, S.B., Wang, H., Unadkat, J.D., Hebert, M.F. & Mao, Q. (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Molecular Pharmacology, 73, 949-959.